What Is China's National Reimbursement Drug List (NRDL)?

adicionou um novo artigo Health

2025-07-01 06:29:13 -

The National Reimbursement Drug List (NRDL) is a cornerstone of China's healthcare system, determining which pharmaceuticals are eligible for reimbursement under the country’s Basic Medical Insurance (BMI) scheme. Managed by the National Healthcare Security Administration (NHSA), the NRDL aims to balance patient access to essential medications with the sustainability of...

0 Comentários 0 Compartilhamentos 917 Visualizações 0 Anterior